A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 in Patients With Migraine
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005906/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the longer term safety of the study drug known as galcanezumab in participants with episodic or chronic migraine.
提供机构：
Vivli
创建时间：
2020-06-08
